Mckesson Corp (MCK) Com Stk Usd0.01

Sell:$823.40Buy:$824.20Price decreased$4.52 (0.55%)

Prices delayed by at least 15 minutes
Sell:$823.40
Buy:$824.20
Change:Price decreased$4.52 (0.55%)
Deal now
Prices delayed by at least 15 minutes
Sell:$823.40
Buy:$824.20
Change:Price decreased$4.52 (0.55%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.

Key people

Brian Scott Tyler
Chief Executive Officer, Director
Britt J. Vitalone
Chief Financial Officer, Executive Vice President
Leann B. Smith
Chief Human Resources Officer, Executive Vice President
Michele Lau
Executive Vice President, Chief Legal Officer
Thomas L. Rodgers
Executive Vice President, Chief Strategy and Business Development Officer
Donald R. Knauss
Independent Chairman of the Board
Dominic J. Caruso
Independent Director
Lynne M. Doughtie
Independent Director
W. Roy Dunbar
Independent Director
Deborah L. Dunsire
Independent Director
Click to see more

Key facts

  • Shares in issue
    279.43m
  • EPIC
    MCK
  • ISIN
    US58155Q1031
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Major Drugs
  • Market cap
    $100.72bn
  • Employees
    43,000
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.